Previous Article | Next Article 
Infection and Immunity, February 2000, p. 688-693, Vol. 68, No. 2
Immunobiology Unit, Institute of Child
Health, University College London,1 and
Department of Microbiology, Great Ormond Street Hospital
for Children,3 NHS Trust, London, and
Immunochemistry Unit, Medical Research Council,
Oxford,2 United Kingdom
Received 6 August 1999/Returned for modification 7 October
1999/Accepted 7 November 1999
Mannose-binding lectin (MBL) is a collagenous serum lectin believed
to be of importance in innate immunity. Genetically determined low
levels of the protein are known to predispose to infections. In this
study the binding of purified MBL to pathogens isolated from
immunocompromised children was investigated by flow cytometry. Diverse
Candida species, Aspergillus fumigatus,
Staphylococcus aureus, and beta-hemolytic group A
streptococci exhibited strong binding of MBL, whereas Escherichia
coli, Klebsiella species, and Haemophilus
influenzae type b were characterized by heterogeneous binding
patterns. In contrast, beta-hemolytic group B streptococci, Streptococcus pneumoniae, and Staphylococcus
epidermidis showed low levels of binding. Bound MBL was able to
promote C4 deposition in a concentration-dependent manner. We conclude
that MBL may be of importance in first-line immune defense against
several important pathogens.
Mannose-binding lectin (MBL) is a
serum protein of hepatic origin belonging to a family of
Ca2+-dependent collagenous lectins, most of which are
components of the innate immune system (10). MBL is able to
bind through multiple sites to various carbohydrate structures
(29, 37) and, on binding to its ligands, is able to activate
complement in an antibody- and C1q-independent manner (12, 24,
26) using MBL-associated serine protease 1 (MASP-1) and MASP-2
(23, 34).
In humans, low levels of MBL are caused by one of three structural
mutations found within exon 1 of the MBL gene (20, 22, 31).
These single point mutations in codons 52, 54, and 57 result in amino
acid substitutions which are believed to interfere with the stability
of the protein (20, 22, 31). Individuals heterozygous for
the codon 54 or 57 mutation are found at relatively high frequency within Eurasian and sub-Saharan African populations, respectively (7, 19, 20, 22, 25), and such mutations have been shown to
be associated with a generalized increased risk of infections (6,
32).
MBL has the potential to express multiple biological effector
functions, but a prerequisite for all such activity is primary binding
to multiple arrays of sugar ligands such as those expressed on
microbial surfaces. However, to date, there have been few detailed studies of the interactions between MBL and a wide range of clinically relevant microorganisms. Here, we report such a study in which, by
using flow cytometry, it has been possible to detect major differences
in the MBL binding capacities of different microorganisms and even
differences among organisms of the same genus. In addition, we have
shown that bound MBL promotes, in a concentration-dependent manner, C4
deposition on the surfaces of organisms.
Preparation of MBL.
MBL was prepared as previously described
by Kilpatrick (17). Briefly, 500 g of frozen
ethanol-fractionated human plasma paste (fraction B+1, equivalent to
Cohn fraction I+III; donated by C. Dash, Blood Products Laboratory,
Elstree, United Kingdom) was purified by ammonium sulfate precipitation
to give 42% saturation. After dialysis the solution was applied to a
mannan-agarose (Sigma, Poole, United Kingdom) column (5-ml packed
volume; Pharmacia Biotech, Uppsala, Sweden) and the calcium-dependent
proteins were eluted with 0.01 M EDTA. The first EDTA eluate was
recalcified to 0.05 M CaCl2, reapplied to the same
mannan-agarose column, and eluted with 0.1 M mannose. The concentration
of MBL was determined by enzyme-linked immunosorbent assay
(19), and sample purity was verified by nonreducing sodium
dodecyl sulfate-polyacrylamide gel electrophoresis using a 3 to 10%
polyacrylamide gradient gel and silver staining. Bands observed on
silver staining were confirmed to be higher-order oligomers of MBL by
immunoblotting and enhanced chemiluminescence detection according to
the method of Lipscombe et al. (21). MBL prepared in this
manner is known to be noncovalently associated with MASP
(23).
Preparation of C4.
C4 was prepared from the plasma of a
single donor by chromatography on Q Sepharose FF, followed by affinity
chromatography using monoclonal (clone L003) anti-C4 Sepharose and
anion exchange using MonoQ (Pharmacia) (2).
Organisms.
The organisms studied comprised isolates from the
nasopharynx and blood cultures from immunocompromised children treated
at Great Ormond Street Hospital for Children. The patient group
included patients with oncological disease undergoing chemotherapy,
children undergoing dialysis while suffering from renal failure, and
patients with a clearly defined immunodeficiency. Isolates were
collected and randomized by the Department of Medical Microbiology.
Organisms were identified by standard laboratory techniques or
classified using API20 NE and API20 Strep (BioMerieux). At least three
different isolates of the same genus were collected. In addition to
these clinical isolates the following organisms were also available for
study: 7 defined strains (Staphylococcus aureus NCTC6571, Pseudomonas aeruginosa NCTC10662, Escherichia
coli NCTC10418, Staphylococcus epidermidis ATCC 1228, Enterobacter aerogenes ATCC 13048, Streptococcus
pneumoniae ATCC 6305, and Candida albicans ATCC 10231),
7 internal quality controls (S. aureus, C. albicans, Candida parapsilosis, Candida
tropicalis, Candida lusitanae, and Cryptococcus
neoformans [n = 2]; Department of Medical
Microbiology), 10 defined S. pneumoniae vaccination strains
(1, 3-6, 9V, 14, 19F, 18, and 23; kindly provided by the Public Health
Laboratory Service), and 2 defined C. neoformans strains (1 encapsulated isolate, B3501, and its coisogenic acapsular mutant, B4131).
Growth and preparation of organisms.
Bacteria and fungi were
cultured as described by Bridson (The Oxoid manual, 7th ed., Oxoid,
Buckinghamshire, United Kingdom). Organisms were subcultured on agar
once before use. Immediately before each experiment organisms were
suspended in Veronal-buffered saline supplemented with 5 mM
CaCl2 and 5 mM MgCl2 at 3 × 108 to 8 × 108 organisms/ml (measured as
an absorbance of 1.0 at 540 nm).
Binding of MBL to organisms.
Binding of MBL to organisms was
performed as previously described by Jack et al. (14).
Briefly, 3 × 108 to 8 × 108
organisms/ml were incubated with 5 µg of MBL/ml for 30 min at 37°C.
After the addition of 2.5 µg of fluorescein isothiocyanate (FITC)-conjugated anti-MBL (FITC-labeled clone 131-1; State Serum Institute, Copenhagen, Denmark; conjugated as described by Johnson and
Holborow [15])/ml and incubation as described above,
MBL binding was measured by flow cytometry performed on a FACS-Calibur at low flow rates using CellQuest software (Becton Dickinson).
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Mannose-Binding Lectin Binds to a Range of
Clinically Relevant Microorganisms and Promotes Complement
Deposition
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Specificity of MBL binding. In order to evaluate whether the binding observed was mediated by C-type lectin interactions, inhibition experiments using different concentrations of monosaccharides (D-mannose and N-acetyl-D-glucosamine) as well as calcium chelating agent EDTA were performed. The monosaccharide or EDTA was added to the MBL solution 10 min prior to the addition of the MBL to six different microorganisms.
Binding of C4 to organisms. The binding of C4 to organisms was performed as previously described by Jack et al. (14) with some modifications. Briefly, 3 × 108 to 8 × 108 organisms/ml were preincubated with MBL for 30 min at 37°C. C4 was added at a concentration of 140 µg/ml, and the organisms were incubated for a further 15 min at 37°C. A mixture of FITC-conjugated anti-MBL and biotinylated anti-C4d (Quidel) was added at a final concentration of 4 µg/ml for each, and the organisms were incubated for 20 min at 37°C. Biotin conjugation of anti-C4d was carried out using standard methodology. Streptavidin-phycoerythrin-Cy 5 (Pharmingen) at a concentration of 0.66 µg/ml was added, and the organisms were incubated as described above. MBL binding and C4 deposition were measured by two-color flow cytometry performed as described above.
| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
Clinical isolates. Over a period of 4 months 54 clinical isolates from either the nasopharynges (n = 30) or cultured blood (n = 24) of immunocompromised children were collected and investigated. These included S. aureus (n = 12), S. epidermidis (n = 6), gram-negative bacterium (n = 12), C. albicans (n = 3), Aspergillus fumigatus (n = 3), beta-hemolytic group A streptococci (n = 5), beta-hemolytic group B streptococci (n = 4), Streptococcus sanguis (n = 2), Enterococcus faecalis (n = 2), and S. pneumoniae (n = 5) isolates.
Flow cytometric analysis. Distinct populations of all of the above organisms could be visualized on the basis of size (forward scatter) and granularity (side scatter) by flow cytometry. Representative population density plots for three of these organisms (S. aureus NCTC6571, C. lusitanae, and E. faecalis) are shown in Fig. 1a to c. The levels of binding of MBL to each of these three organisms also differed markedly and are shown in Fig. 1d to f.
|
Binding of MBL to microorganisms. The commonest isolate studied was S. aureus. Eight isolates were collected from the nasopharynx, and four isolates were from blood culture. All isolates of S. aureus (n = 12), including three methicillin-resistant isolates, were found to bind MBL in the moderate and high categories. Similar binding patterns were also seen with C. albicans (n = 3) and A. fumigatus (n = 3). In addition, all beta-hemolytic group A streptococci (n = 5), three isolates collected from the nasopharynx and two isolates from blood culture, showed a distinct pattern of MBL deposition, with 60 to 80% of the organisms binding the protein. In contrast, all beta-hemolytic group B streptococci (n = 4), all S. pneumoniae isolates (n = 5), and two isolates each of E. faecalis and S. sanguis showed low binding. The same results were obtained when selected S. pneumoniae isolates were grown in log phase. Similarly S. epidermidis (n = 6) generally demonstrated low binding activity except for one isolate, which showed moderate binding. Most gram-negative isolates (n = 12) bound little or no MBL, apart from one isolate each of E. coli, Klebsiella aerogenes, and Haemophilus influenzae type b showing high or moderate MBL binding. The E. coli and K. aerogenes strains were isolated from blood cultures obtained from the same patient, who was subsequently shown to be heterozygous for the codon 54 mutation of the MBL gene.
In many analyses it was noted that a minority of organisms (up to 20%) bound MBL whereas the majority showed no such binding. In Fig. 2a a typical example of such a pattern is shown. Further analysis of the binding population (Fig. 2c) failed to demonstrate any distinctive features (e.g., in size and granularity) compared to the population as a whole, shown in Fig. 2b, indicating that the binding was not due to clumping or major disruption of the organisms. However, the intensity of the binding was always low, so, compared to background staining (in the absence of MBL) little difference was observed.
|
|
|
Specificity of MBL binding. MBL binding to six representative organisms was markedly reduced in the presence of 10 mM EDTA, demonstrating the divalent-cation-dependent nature of the observed interactions (Fig. 5). In addition mannose and N-acetylglucosamine inhibited binding of MBL in a dose-dependent manner.
|
). The monosaccharide or
EDTA was added to the MBL solution 10 min prior to the addition of the
MBL to the organisms. Each point represents the mean ± standard
error of the mean of the MFI for three independent experiments.
Overall summary of observed MBL binding patterns. In total 80 microorganisms were studied (clinical isolates and defined strains). The results, expressed as the ratio of median fluorescence using 5 µg of MBL/ml relative to the appropriate control, are illustrated in Fig. 6. Nearly half of the organisms bound MBL. However, three patterns of binding were observed. All isolates from S. aureus, C. albicans, A. fumigatus, and beta-hemolytic group A streptococci showed MBL binding. For several organisms a single isolate was observed to exhibit binding (E. coli, K. aerogenes, H. influenzae type b, S. epidermidis, and nonencapsulated C. neoformans). For six of the organisms (beta-hemolytic group B streptococci, S. pneumoniae, S. sanguis, E. faecalis, non-type b H. influenzae, and P. aeruginosa) there was no evidence of binding with any of the isolates tested.
|
-haem. Strep. A indicates beta-hemolytic group A
streptococcus.
Binding of C4. In order to investigate the ability of MBL and MASP bound to different organisms to activate the complement system, purified C4 was added to suspensions of three selected organisms. MBL at a range of concentrations (0 to 2.5 µg/ml) was preincubated with these organisms before exposure to C4 (140 µg/ml). As shown in Fig. 7, MBL concentration-dependent C4 binding was observed with S. aureus NCTC6571 and one strain of Klebsiella whereas no C4 was bound by another strain of Klebsiella, which had previously been shown not to bind MBL.
|
) and one strain of Klebsiella
(
) were selected for their known ability to bind MBL, whereas
another strain of Klebsiella (
) did not bind to the
protein. Each point represents the mean ± the standard error of
the mean of the MFI for three independent experiments.
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
The acquisition of detailed knowledge of the fine structure of MBL has been paralleled by a series of publications reporting significant binding of this collectin to particular microorganisms. Such reports have presented evidence of MBL binding to individual pathogens, including human immunodeficiency virus type 1 and influenza A virus (4, 8, 9), and to the yeasts C. albicans and C. neoformans (28, 33). There have also been studies of MBL binding to various bacteria such as Salmonella enterica serovar Montevideo (18), E. coli (16), Mycobacterium avium (27), and Neisseria meningitidis (14). To the best of our knowledge only one other study has attempted a more comprehensive investigation of binding. This was the report by van Emmerik et al. (36), which described studies using radiolabeled MBL and which focused on organisms known to cause meningeal disease (e.g., Listeria monocytogenes, streptococci, H. influenzae type b, and Neisseria species).
In the present study we have used a flow cytometric methodology developed and refined in a previous study (14) to investigate a wide range of clinically relevant microorganisms. In addition to being a nonisotopic procedure, this has the advantage that single organisms can be visualized and specificity controls can be readily incorporated.
We were particularly concerned that misleading results could arise if surface lectins expressed by the bacteria were able to interact with sugar groups on the MBL molecule. We have attempted to control for this by performing calcium chelation and dose-dependent inhibition experiments using N-acetylglucosamine and mannose with each organism exhibiting strong binding of MBL. The concordance observed suggests that the binding was indeed between the C-type lectin domain of MBL and sugar groups expressed on the surfaces of organisms.
While the binding of MBL to simple sugars is relatively well understood (3, 13, 29, 37, 38), the binding to complex microbial structures and surfaces has not been extensively studied. Although the variation in expression of mannose structures has been shown to alter MBL binding (18, 27), it is likely that in many instances pathogens also utilize other structures to evade MBL binding. The expression of capsular polysaccharide has been shown to decrease the binding of MBL to N. meningitidis serogroup B and H. influenzae type b (36) and to C. neoformans (28). The structure and composition of bacterial endotoxins have also been shown to have a major influence on MBL binding (11, 14). These structures appear to be able to mask ligands to which MBL could bind (e.g., mannose and N-acetylglucosamine) or may alter the sugar conformation or density to prevent MBL binding.
For certain microorganisms every isolate studied bound MBL unequivocally, although there was considerable variation in the amount deposited on the microbial surface as determined by measuring the MFI of binding. Examples of such organisms included S. aureus, C. albicans, A. fumigatus, and beta-hemolytic group A streptococcus. However, one of the most striking findings in this study was the identification of heterogeneity in MBL binding for certain organisms such as E. coli, Klebsiella species, and H. influenzae type b. This emphasizes the need to study several isolates of a particular organism before concluding that MBL either binds or does not bind.
It was noteworthy that in many of the analyses reported here a significant proportion of organisms (up to 20%) were observed to bind MBL (visualized typically as a tail in the fluorescence histogram) while the majority of organisms showed no such binding. Initially it was considered that this might be a technical artifact. However, the binding population failed to demonstrate any gross distinctive features (size and granularity) compared to the population as a whole. This suggests that the binding was not due to clumping or major disruption of the organisms. An alternative explanation is that it represents organisms expressing sugar arrays differing from those of the nonbinding majority. Such differences could reflect experimental damage or simply natural variation.
At the time of primary contact with any microorganism the role of the innate immune system, including MBL, is paramount. For this reason individuals who are homozygous for the structural gene mutations are believed to be at increased risk of infection, and several studies support this (5, 6, 32). However, heterozygous individuals also manifest significant reductions in protein level (typically 0.3 to 0.6 µg/ml) (20), and MBL binding to S. aureus at these concentrations was shown to be markedly impaired in this study.
We were also able to demonstrate a close relationship between C4 deposition and initial MBL concentration for both S. aureus NCTC6571 and one strain of Klebsiella. At an MBL concentration of 0.3 µg/ml there was minimal C4 deposition, but at 1.3 µg of MBL/ml significant levels of C4 could be detected. It is reasonable to extrapolate from these findings and conclude that C3b deposition would parallel the C4 results. The latter may therefore be regarded as a surrogate for MBL-mediated opsonophagocytosis.
It was of interest that two of the clinical isolates of organisms showing heterogeneity in MBL binding (K. aerogenes and E. coli) were from the same patient and that that particular individual was heterozygous for the codon 54 mutation of the MBL gene. There is, at present, no clear evidence about the minimal levels of MBL which might be protective against particular pathogens. The levels of MBL required may be dependent upon the nature of the infectious agent and/or variations in host defense mechanisms. Arriving at such estimates will pose formidable difficulties until we have more data on the relative importance of the various clearance mechanisms involved. In some cases simple steric hindrance by MBL may effectively inhibit the spread of organisms by blocking access to appropriate receptors. In other cases direct opsonic adherence or, more likely, complement activation and the deposition of C3b opsonins will be the critical routes of elimination. Recent evidence has also indicated that MBL can modulate the host inflammatory response to infections (1, 30). All of these aspects should be the target of further research and will help to identify the clinical situations in which MBL replacement or adjunctive therapy (35) might play a positive role.
| |
ACKNOWLEDGMENTS |
|---|
O.N. was supported by the Dr. Mildred Scheel Stiftung für Krebsforschung, Germany. D.L.J. is supported by the Wellcome Trust, United Kingdom.
We are grateful for the help and assistance of members of the Microbiology Department, Great Ormond Street Hospital For Children. We also thank D. Goldblatt for providing selected isolates of S. pneumoniae and G. Bancroft for providing the acapsular mutant of C. neoformans.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Immunobiology Unit, Institute of Child Health, 30 Guilford St., London, United Kingdom WC1N 1EH. Phone: 0044-171-2079-052215. Fax: 0044-2078-8138494. E-mail: mturner{at}ich.ucl.ac.uk.
Editor: T. R. Kozel
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
| 1. | Chaka, W., A. F. M. Verheul, V. V. Vaishnav, R. Cherniak, J. Scharringa, J. Verhof, H. Snippe, and A. I. M. Hoepelman. 1997. TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J. Immunol. 159:2979-2985[Abstract]. |
| 2. | Dodds, A. W. 1993. Small scale preparation of complement components C3 and C4. Methods Enzymol. 223:46-61[Medline]. |
| 3. | Drickamer, K. 1992. Engineering galactose-binding activity into a C-type mannose-binding protein. Nature 360:183-186[CrossRef][Medline]. |
| 4. |
Ezekowitz, R. A. B.,
M. Kuhlman,
J. E. Groopman, and R. A. Byrn.
1989.
A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus.
J. Exp. Med.
169:185-196 |
| 5. | Garred, P., H. O. Madsen, U. Balsev, B. Hofmann, C. Pedersen, J. Gerstoft, and A. Svejgaard. 1997. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 349:236-240[CrossRef][Medline]. |
| 6. | Garred, P., H. O. Madsen, B. Hofmann, and A. Svejgaard. 1995. Increased frequency of homozygosity of abnormal mannan-binding protein alleles in patients with suspected immunodeficiency. Lancet 346:941-943[CrossRef][Medline]. |
| 7. | Garred, P., H. O. Madsen, J. A. Kurtzhals, L. U. Lamm, S. Thiel, A. S. Hey, and A. Svejgaard. 1992. Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur. J. Immunogenet. 19:403-412[Medline]. |
| 8. | Hartshorn, K. L., K. Sastry, M. R. White, E. M. Anders, M. Super, R. A. Ezekowitz, and A. I. Tauber. 1993. Human mannose-binding protein functions as an opsonin for influenza A viruses. J. Clin. Investig. 91:1414-1420. |
| 9. | Haurum, J. S., S. Thiel, I. M. Jones, P. B. Fischer, S. B. Laursen, and J. C. Jensenius. 1993. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 7:1307-1313[Medline]. |
| 10. | Holmskov, U., R. Malhotra, R. B. Sim, and J. C. Jensenius. 1994. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol. Today 15:67-74[CrossRef][Medline]. |
| 11. | Ihara, I., Y. Harada, S. Ihara, and M. Kawakami. 1982. A new complement-dependent bactericidal factor found in nonimmune mouse sera: specific binding to polysaccharide of Ra chemotype Salmonella. J. Immunol. 128:1256-1260[Abstract]. |
| 12. |
Ikeda, K.,
T. Sannoh,
N. Kawasaki,
T. Kawasaki, and I. Yamashina.
1987.
Serum lectin with known structure activates complement through the classical pathway.
J. Biol. Chem.
262:7451-7454 |
| 13. |
Iobst, S. T., and K. Drickamer.
1994.
Binding of sugar ligands to Ca2+-dependent animal lectins. II. Generation of high-affinity galactose binding by site-directed mutagenesis.
J. Biol. Chem.
269:15512-15519 |
| 14. |
Jack, D. L.,
A. W. Dodds,
N. Anwar,
C. A. Ison,
A. Law,
M. Frosch,
M. Turner, and N. J. Klein.
1998.
Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B.
J. Immunol.
160:1346-1353 |
| 15. | Johnson, G. D., and E. J. Holborow. 1973. Immunofluorescence, p. 18.1-18.20. In D. M. Weir (ed.), Handbook of experimental immunology, 2nd ed. Blackwell Scientific Publications Ltd., Oxford, England. |
| 16. |
Kawasaki, N.,
T. Kawasaki, and I. Yamashina.
1989.
A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity.
J. Biochem.
106:483-489 |
| 17. | Kilpatrick, D. C. 1997. Isolation of human mannan binding lectin, serum amyloid P component and related factors from Cohn fraction III. Transfus. Med. 7:289-294[CrossRef][Medline]. |
| 18. |
Kuhlman, M.,
K. Joiner, and R. A. Ezekowitz.
1989.
The human mannose-binding protein functions as an opsonin.
J. Exp. Med.
169:1733-1745 |
| 19. | Lipscombe, R. J., D. W. Beatty, M. Ganczakowski, E. A. Goddard, T. Jenkins, Y.-L. Lau, A. B. Spurdle, M. Sumiya, J. A. Summerfield, and M. W. Turner. 1996. Mutations in the human mannan binding lectin gene: frequencies in several population groups. Eur. J. Hum. Genet. 4:13-19[Medline]. |
| 20. |
Lipscombe, R. J.,
M. Sumiya,
A. V. Hill,
Y. L. Lau,
R. J. Levinsky,
J. A. Summerfield, and M. W. Turner.
1992.
High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene.
Hum. Mol. Genet.
1:709-715 |
| 21. | Lipscombe, R. J., M. Sumiya, J. A. Summerfield, and M. W. Turner. 1995. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 85:660-667[Medline]. |
| 22. | Madsen, H. O., P. Garred, J. A. Kurtzhals, L. U. Lamm, L. P. Ryder, S. Thiel, and A. Svejgaard. 1994. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 40:37-44[CrossRef][Medline]. |
| 23. |
Matsushita, M., and T. Fujita.
1992.
Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease.
J. Exp. Med.
176:1497-1502 |
| 24. | Matsushita, M., A. Takahashi, H. Hatsuse, M. Kawakami, and T. Fujita. 1992. Human mannose-binding protein is identical to a component of Ra-reactive factor. Biochem. Biophys. Res. Commun. 183:645-651[CrossRef][Medline]. |
| 25. | Mead, R., D. Jack, M. Pembrey, L. Tyfield, M. Turner, and the ALSPAC Study Team. 1997. Mannose-binding lectin alleles in a prospectively recruited UK population. Lancet 349:1669-1670[CrossRef][Medline]. |
| 26. |
Ohta, M.,
M. Okada,
I. Yamashina, and T. Kawasaki.
1990.
The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein.
J. Biol. Chem.
265:1980-1984 |
| 27. | Polotsky, V. Y., J. T. Belisle, K. Mikusova, R. A. B. Ezekowitz, and K. A. Joiner. 1997. Interaction of human mannose-binding protein with Mycobacterium avium. J. Infect. Dis. 175:1159-1168[Medline]. |
| 28. | Schelenz, S., R. Malhotra, R. B. Sim, U. Holmskov, and G. J. Bancroft. 1995. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect. Immun. 63:3360-3366[Abstract]. |
| 29. |
Sheriff, S.,
C. Y. Chang, and R. A. B. Ezekowitz.
1994.
Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple  -helical coiled-coil.
Nat. Struct. Biol.
1:789-794[CrossRef][Medline].
|
| 30. | Soell, M., E. Lett, F. Holveck, M. Scholler, D. Wachsmann, and J. P. Klein. 1995. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-alpha release. J. Immunol. 154:851-860[Abstract]. |
| 31. | Sumiya, M., M. Super, P. Tabona, R. J. Levinsky, T. Arai, M. W. Turner, and J. A. Summerfield. 1991. Molecular basis of opsonic defect in immunodeficient children. Lancet 337:1569-1570[CrossRef][Medline]. |
| 32. |
Summerfield, J. A.,
M. Sumiya,
M. Levin, and M. W. Turner.
1997.
Association of mutations in mannose binding protein gene with childhood infections in consecutive hospital series.
Br. Med. J.
314:1229-1232 |
| 33. |
Tabona, P.,
A. Mellor, and J. A. Summerfield.
1995.
Mannose-binding protein is involved in first-line host-defense evidence from transgenic mice.
Immunology
85:153-159[Medline].
|
| 34. | Thiel, S., T. Vorup-Jensen, C. M. Stover, W. Schwaeble, S. B. Laursen, K. Poulsen, A. C. Willis, P. Eggleton, S. Hansen, U. Holmskov, K. B. M. Reid, and J. Jensenius. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386:506-510[CrossRef][Medline]. |
| 35. | Valdimarsson, H., M. Stefansson, T. Vikingsdottir, G. J. Arason, C. Koch, S. Thiel, and J. Jensenius. 1998. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand. J. Immunol. 48:116-123[CrossRef][Medline]. |
| 36. | van Emmerik, L. C., E. J. Kuijper, C. A. Fijen, J. Dankert, and S. Thiel. 1994. Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin. Exp. Immunol. 97:411-416[Medline]. |
| 37. | Weis, W. I., and K. Drickamer. 1994. Trimeric structure of a C-type mannose-binding protein. Structure 2:1227-1240[Medline]. |
| 38. | Weis, W. I., K. Drickamer, and W. A. Hendrickson. 1992. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 360:127-134[CrossRef][Medline]. |
Infection and Immunity, February 2000, p. 688-693, Vol. 68, No. 2
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ma, Y. J., Doni, A., Hummelshoj, T., Honore, C., Bastone, A., Mantovani, A., Thielens, N. M., Garred, P.
(2009). Synergy between Ficolin-2 and Pentraxin 3 Boosts Innate Immune Recognition and Complement Deposition. J. Biol. Chem.
284: 28263-28275
[Abstract] [Full Text] -
Park, S. J., Mehrad, B.
(2009). Innate Immunity to Aspergillus Species. Clin. Microbiol. Rev.
22: 535-551
[Abstract] [Full Text] -
Zuo, D.-M., Zhang, L.-Y., Lu, X., Liu, Y., Chen, Z.-L.
(2009). Protective role of mouse MBL-C on intestinal mucosa during Shigella flexneri invasion. Int Immunol
21: 1125-1134
[Abstract] [Full Text] -
Dagenais, T. R. T., Keller, N. P.
(2009). Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clin. Microbiol. Rev.
22: 447-465
[Abstract] [Full Text] -
Oliva, A.-M., Pavan, P. R., Margo, C. E., Pautler, S. E.
(2009). Recalcitrant Candida Endophthalmitis Associated With Mannose-Binding Lectin Deficiency. Arch Ophthalmol
127: 822-823
[Full Text] -
Norup, L. R., Dalgaard, T. S., Friggens, N. C., Sorensen, P., Juul-Madsen, H. R.
(2009). Influence of chicken serum mannose-binding lectin levels on the immune response towards Escherichia coli. Poult. Sci.
88: 543-553
[Abstract] [Full Text] -
Fidler, K J, Hilliard, T N, Bush, A, Johnson, M, Geddes, D M, Turner, M W, Alton, E W F W, Klein, N J, Davies, J C
(2009). Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism. Thorax
64: 150-155
[Abstract] [Full Text] -
Endeman, H., Herpers, B. L., de Jong, B. A. W., Voorn, G. P., Grutters, J. C., van Velzen-Blad, H., Biesma, D. H.
(2008). Mannose-Binding Lectin Genotypes in Susceptibility to Community-Acquired Pneumonia. Chest
134: 1135-1140
[Abstract] [Full Text] -
Dumestre-Perard, C., Lamy, B., Aldebert, D., Lemaire-Vieille, C., Grillot, R., Brion, J.-P., Gagnon, J., Cesbron, J.-Y.
(2008). Aspergillus Conidia Activate the Complement by the Mannan-Binding Lectin C2 Bypass Mechanism. J. Immunol.
181: 7100-7105
[Abstract] [Full Text] -
Ramasawmy, R., Spina, G. S., Fae, K. C., Pereira, A. C., Nisihara, R., Messias Reason, I. J., Grinberg, M., Tarasoutchi, F., Kalil, J., Guilherme, L.
(2008). Association of Mannose-Binding Lectin Gene Polymorphism but Not of Mannose-Binding Serine Protease 2 with Chronic Severe Aortic Regurgitation of Rheumatic Etiology. CVI
15: 932-936
[Abstract] [Full Text] -
Brouwer, N., Dolman, K. M., van Houdt, M., Sta, M., Roos, D., Kuijpers, T. W.
(2008). Mannose-Binding Lectin (MBL) Facilitates Opsonophagocytosis of Yeasts but Not of Bacteria despite MBL Binding. J. Immunol.
180: 4124-4132
[Abstract] [Full Text] -
Koneti, A., Linke, M. J., Brummer, E., Stevens, D. A.
(2008). Evasion of Innate Immune Responses: Evidence for Mannose Binding Lectin Inhibition of Tumor Necrosis Factor Alpha Production by Macrophages in Response to Blastomyces dermatitidis. Infect. Immun.
76: 994-1002
[Abstract] [Full Text] -
Aoyagi, Y., Adderson, E. E., Rubens, C. E., Bohnsack, J. F., Min, J. G., Matsushita, M., Fujita, T., Okuwaki, Y., Takahashi, S.
(2008). L-Ficolin/Mannose-Binding Lectin-Associated Serine Protease Complexes Bind to Group B Streptococci Primarily through N-Acetylneuraminic Acid of Capsular Polysaccharide and Activate the Complement Pathway. Infect. Immun.
76: 179-188
[Abstract] [Full Text] -
van Till, J. W. O., Modderman, P. W., de Boer, M., Hart, M. H. L., Beld, M. G. H. M., Boermeester, M. A.
(2008). Mannose-Binding Lectin Deficiency Facilitates Abdominal Candida Infections in Patients with Secondary Peritonitis. CVI
15: 65-70
[Abstract] [Full Text] -
Bulgakov, A. A, Eliseikina, M. G, Petrova, I. Y., Nazarenko, E. L, Kovalchuk, S. N, Kozhemyako, V. B, Rasskazov, V. A
(2007). Molecular and Biological Characterization of a Mannan-Binding Lectin from the Holothurian Apostichopus Japonicus. Glycobiology
17: 1284-1298
[Abstract] [Full Text] -
Panepinto, J. C., Komperda, K. W., Hacham, M., Shin, S., Liu, X., Williamson, P. R.
(2007). Binding of Serum Mannan Binding Lectin to a Cell Integrity-Defective Cryptococcus neoformans ccr4{Delta} Mutant. Infect. Immun.
75: 4769-4779
[Abstract] [Full Text] -
Sziller, I., Babula, O., Ujhazy, A., Nagy, B., Hupuczi, P., Papp, Z., Linhares, I.M., Ledger, W.J., Witkin, S.S.
(2007). Chlamydia trachomatis infection, Fallopian tube damage and a mannose-binding lectin codon 54 gene polymorphism. Hum Reprod
22: 1861-1865
[Abstract] [Full Text] -
Sziller, I., Babula, O., Hupuczi, P., Nagy, B., Rigo, B., Szabo, G., Papp, Z., Linhares, I.M., Witkin, S.S.
(2007). Mannose-binding lectin (MBL) codon 54 gene polymorphism protects against development of pre-eclampsia, HELLP syndrome and pre-eclampsia-associated intrauterine growth restriction. Mol Hum Reprod
13: 281-285
[Abstract] [Full Text] -
Smithson, A., Munoz, A., Suarez, B., Soto, S. M., Perello, R., Soriano, A., Martinez, J. A., Vila, J., Horcajada, J. P., Mensa, J., Lozano, F.
(2007). Association between Mannose-Binding Lectin Deficiency and Septic Shock following Acute Pyelonephritis Due to Escherichia coli. CVI
14: 256-261
[Abstract] [Full Text] -
Iwaki, D., Kanno, K., Takahashi, M., Endo, Y., Lynch, N. J., Schwaeble, W. J., Matsushita, M., Okabe, M., Fujita, T.
(2006). Small Mannose-Binding Lectin-Associated Protein Plays a Regulatory Role in the Lectin Complement Pathway. J. Immunol.
177: 8626-8632
[Abstract] [Full Text] -
Moller-Kristensen, M., Ip, W. K. E., Shi, L., Gowda, L. D., Hamblin, M. R., Thiel, S., Jensenius, J. Chr., Ezekowitz, R. A. B., Takahashi, K.
(2006). Deficiency of Mannose-Binding Lectin Greatly Increases Susceptibility to Postburn Infection with Pseudomonas aeruginosa. J. Immunol.
176: 1769-1775
[Abstract] [Full Text] -
Lam, M. F., Leung, J. C. K., Tang, C. C. S., Lo, W. K., Tse, K. C., Yip, T. P., Lui, S. L., Chan, T. M., Lai, K. N.
(2005). Mannose binding lectin level and polymorphism in patients on long-term peritoneal dialysis. Nephrol Dial Transplant
20: 2489-2496
[Abstract] [Full Text] -
Hamvas, R. M. J., Johnson, M., Vlieger, A. M., Ling, C., Sherriff, A., Wade, A., Klein, N. J., Turner, M. W., The ALSPAC Study Team, , Webster, A. D. B.
(2005). Role for Mannose Binding Lectin in the Prevention of Mycoplasma Infection. Infect. Immun.
73: 5238-5240
[Abstract] [Full Text] -
Nadesalingam, J., Dodds, A. W., Reid, K. B. M., Palaniyar, N.
(2005). Mannose-Binding Lectin Recognizes Peptidoglycan via the N-Acetyl Glucosamine Moiety, and Inhibits Ligand-Induced Proinflammatory Effect and Promotes Chemokine Production by Macrophages. J. Immunol.
175: 1785-1794
[Abstract] [Full Text] -
Teillet, F., Dublet, B., Andrieu, J.-P., Gaboriaud, C., Arlaud, G. J., Thielens, N. M.
(2005). The Two Major Oligomeric Forms of Human Mannan-Binding Lectin: Chemical Characterization, Carbohydrate-Binding Properties, and Interaction with MBL-Associated Serine Proteases. J. Immunol.
174: 2870-2877
[Abstract] [Full Text] -
Krarup, A., Sorensen, U. B. S., Matsushita, M., Jensenius, J. C., Thiel, S.
(2005). Effect of Capsulation of Opportunistic Pathogenic Bacteria on Binding of the Pattern Recognition Molecules Mannan-Binding Lectin, L-Ficolin, and H-Ficolin. Infect. Immun.
73: 1052-1060
[Abstract] [Full Text] -
Baelder, R., Fuchs, B., Bautsch, W., Zwirner, J., Kohl, J., Hoymann, H. G, Glaab, T., Erpenbeck, V., Krug, N., Braun, A.
(2005). Pharmacological Targeting of Anaphylatoxin Receptors during the Effector Phase of Allergic Asthma Suppresses Airway Hyperresponsiveness and Airway Inflammation. J. Immunol.
174: 783-789
[Abstract] [Full Text] -
Aoyagi, Y., Adderson, E. E., Min, J. G., Matsushita, M., Fujita, T., Takahashi, S., Okuwaki, Y., Bohnsack, J. F.
(2005). Role of L-Ficolin/Mannose-Binding Lectin-Associated Serine Protease Complexes in the Opsonophagocytosis of Type III Group B Streptococci. J. Immunol.
174: 418-425
[Abstract] [Full Text] -
Ma, Y. G., Cho, M. Y., Zhao, M., Park, J. W., Matsushita, M., Fujita, T., Lee, B. L.
(2004). Human Mannose-binding Lectin and L-Ficolin Function as Specific Pattern Recognition Proteins in the Lectin Activation Pathway of Complement. J. Biol. Chem.
279: 25307-25312
[Abstract] [Full Text] -
Dahl, M., Tybjaerg-Hansen, A., Schnohr, P., Nordestgaard, B. G.
(2004). A Population-based Study of Morbidity and Mortality in Mannose-binding Lectin Deficiency. JEM
199: 1391-1399
[Abstract] [Full Text] -
Larsen, F., Madsen, H. O., Sim, R. B., Koch, C., Garred, P.
(2004). Disease-associated Mutations in Human Mannose-binding Lectin Compromise Oligomerization and Activity of the Final Protein. J. Biol. Chem.
279: 21302-21311
[Abstract] [Full Text] -
Ferguson, J. S., Weis, J. J., Martin, J. L., Schlesinger, L. S.
(2004). Complement Protein C3 Binding to Mycobacterium tuberculosis Is Initiated by the Classical Pathway in Human Bronchoalveolar Lavage Fluid. Infect. Immun.
72: 2564-2573
[Abstract] [Full Text] -
Mueller-Ortiz, S. L., Drouin, S. M., Wetsel, R. A.
(2004). The Alternative Activation Pathway and Complement Component C3 Are Critical for a Protective Immune Response against Pseudomonas aeruginosa in a Murine Model of Pneumonia. Infect. Immun.
72: 2899-2906
[Abstract] [Full Text] -
Hogaboam, C. M., Takahashi, K., Ezekowitz, R. A. B., Kunkel, S. L., Schuh, J. M.
(2004). Mannose-binding lectin deficiency alters the development of fungal asthma: effects on airway response, inflammation, and cytokine profile. J. Leukoc. Biol.
75: 805-814
[Abstract] [Full Text] -
Estabrook, M. M., Jack, D. L., Klein, N. J., Jarvis, G. A.
(2004). Mannose-Binding Lectin Binds to Two Major Outer Membrane Proteins, Opacity Protein and Porin, of Neisseria meningitidis. J. Immunol.
172: 3784-3792
[Abstract] [Full Text] -
de Haas, C. J.C., Veldkamp, K. E., Peschel, A., Weerkamp, F., Van Wamel, W. J.B., Heezius, E. C.J.M., Poppelier, M. J.J.G., Van Kessel, K. P.M., van Strijp, J. A.G.
(2004). Chemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent. JEM
199: 687-695
[Abstract] [Full Text] -
Lynch, N. J., Roscher, S., Hartung, T., Morath, S., Matsushita, M., Maennel, D. N., Kuraya, M., Fujita, T., Schwaeble, W. J.
(2004). L-Ficolin Specifically Binds to Lipoteichoic Acid, a Cell Wall Constituent of Gram-Positive Bacteria, and Activates the Lectin Pathway of Complement. J. Immunol.
172: 1198-1202
[Abstract] [Full Text] -
Romani, L., Montagnoli, C., Bozza, S., Perruccio, K., Spreca, A., Allavena, P., Verbeek, S., Calderone, R. A., Bistoni, F., Puccetti, P.
(2004). The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. Int Immunol
16: 149-161
[Abstract] [Full Text] -
Carlsson, F., Berggard, K., Stalhammar-Carlemalm, M., Lindahl, G.
(2003). Evasion of Phagocytosis through Cooperation between Two Ligand-binding Regions in Streptococcus pyogenes M Protein. JEM
198: 1057-1068
[Abstract] [Full Text] -
Kvalsvig, A J, Unsworth, D J
(2003). The immunopathogenesis of meningococcal disease. J. Clin. Pathol.
56: 417-422
[Abstract] [Full Text] -
Rogers, P. D., Thornton, J., Barker, K. S., McDaniel, D. O., Sacks, G. S., Swiatlo, E., McDaniel, L. S.
(2003). Pneumolysin-Dependent and -Independent Gene Expression Identified by cDNA Microarray Analysis of THP-1 Human Mononuclear Cells Stimulated by Streptococcus pneumoniae. Infect. Immun.
71: 2087-2094
[Abstract] [Full Text] -
Hart, M. L., Saifuddin, M., Spear, G. T.
(2003). Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin. J. Gen. Virol.
84: 353-360
[Abstract] [Full Text] -
Brown, J. S., Hussell, T., Gilliland, S. M., Holden, D. W., Paton, J. C., Ehrenstein, M. R., Walport, M. J., Botto, M.
(2002). The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc. Natl. Acad. Sci. USA
99: 16969-16974
[Abstract] [Full Text] -
Lee, S. J., Gonzalez-Aseguinolaza, G., Nussenzweig, M. C.
(2002). Disseminated Candidiasis and Hepatic Malarial Infection in Mannose-Binding-Lectin-A-Deficient Mice. Mol. Cell. Biol.
22: 8199-8203
[Abstract] [Full Text] -
Hartshorn, K. L., White, M. R., Crouch, E. C.
(2002). Contributions of the N- and C-Terminal Domains of Surfactant Protein D to the Binding, Aggregation, and Phagocytic Uptake of Bacteria. Infect. Immun.
70: 6129-6139
[Abstract] [Full Text] -
Zamze, S., Martinez-Pomares, L., Jones, H., Taylor, P. R., Stillion, R. J., Gordon, S., Wong, S. Y. C.
(2002). Recognition of Bacterial Capsular Polysaccharides and Lipopolysaccharides by the Macrophage Mannose Receptor. J. Biol. Chem.
277: 41613-41623
[Abstract] [Full Text] -
Neth, O., Jack, D. L., Johnson, M., Klein, N. J., Turner, M. W.
(2002). Enhancement of Complement Activation and Opsonophagocytosis by Complexes of Mannose-Binding Lectin with Mannose-Binding Lectin-Associated Serine Protease After Binding to Staphylococcus aureus. J. Immunol.
169: 4430-4436
[Abstract] [Full Text] -
Scanlan, C. N., Pantophlet, R., Wormald, M. R., Ollmann Saphire, E., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., Burton, D. R.
(2002). The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of {alpha}1->2 Mannose Residues on the Outer Face of gp120. J. Virol.
76: 7306-7321
[Abstract] [Full Text] -
Mullighan, C. G., Heatley, S., Doherty, K., Szabo, F., Grigg, A., Hughes, T. P., Schwarer, A. P., Szer, J., Tait, B. D., Bik To, L., Bardy, P. G.
(2002). Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood
99: 3524-3529
[Abstract] [Full Text] -
van Crevel, R., Ottenhoff, T. H. M., van der Meer, J. W. M.
(2002). Innate Immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev.
15: 294-309
[Abstract] [Full Text] -
Wilson, J W, Schurr, M J, LeBlanc, C L, Ramamurthy, R, Buchanan, K L, Nickerson, C A
(2002). Mechanisms of bacterial pathogenicity. Postgrad. Med. J.
78: 216-224
[Abstract] [Full Text] -
Marr, K. A., Koudadoust, M., Black, M., Balajee, S. A.
(2001). Early Events in Macrophage Killing of Aspergillus fumigatus Conidia: New Flow Cytometric Viability Assay. CVI
8: 1240-1247
[Abstract] [Full Text] -
Hansen, T. K., Thiel, S., Dall, R., Rosenfalck, A. M., Trainer, P., Flyvbjerg, A., Jorgensen, J. O. L., Christiansen, J. S.
(2001). GH Strongly Affects Serum Concentrations of Mannan-Binding Lectin: Evidence for a New IGF-I Independent Immunomodulatory Effect of GH. J. Clin. Endocrinol. Metab.
86: 5383-5388
[Abstract] [Full Text] -
Roos, A., Bouwman, L. H., van Gijlswijk-Janssen, D. J., Faber-Krol, M. C., Stahl, G. L., Daha, M. R.
(2001). Human IgA Activates the Complement System Via the Mannan-Binding Lectin Pathway. J. Immunol.
167: 2861-2868
[Abstract] [Full Text] -
Devyatyarova-Johnson, M., Rees, I. H., Robertson, B. D., Turner, M. W., Klein, N. J., Jack, D. L.
(2000). The Lipopolysaccharide Structures of Salmonella enterica Serovar Typhimurium and Neisseria gonorrhoeae Determine the Attachment of Human Mannose-Binding Lectin to Intact Organisms. Infect. Immun.
68: 3894-3899
[Abstract] [Full Text] -
Turner, M. W., Dinan, L., Heatley, S., Jack, D. L., Boettcher, B., Lester, S., McCluskey, J., Roberton, D.
(2000). Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians. Hum Mol Genet
9: 1481-1486
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»